Cargando…
A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program
BACKGROUND: Paclitaxel-eluting stents decrease angiographic and clinical restenosis following percutaneous coronary intervention compared to bare metal stents. TAXUS Element is a third-generation paclitaxel-eluting stent which incorporates a novel, thinner-strut, platinum-enriched metal alloy platfo...
Autores principales: | Allocco, Dominic J, Cannon, Louis A, Britt, Amy, Heil, John E, Nersesov, Andrey, Wehrenberg, Scott, Dawkins, Keith D, Kereiakes, Dean J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826324/ https://www.ncbi.nlm.nih.gov/pubmed/20059766 http://dx.doi.org/10.1186/1745-6215-11-1 |
Ejemplares similares
-
A Prospective, Randomized Comparison of Promus Everolimus-Eluting and TAXUS Liberte Paclitaxel-Eluting Stent Systems in Patients with Coronary Artery Disease Eligible for Percutaneous Coronary Intervention: The PROMISE Study
por: Kim, Ung, et al.
Publicado: (2013) -
Everolimus-eluting stents: update on current clinical studies
por: Allocco, Dominic J, et al.
Publicado: (2011) -
Efficacies of the new Paclitaxel-eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO-PLEASANT) trial: study rationale and design
por: Seo, Jae-Bin, et al.
Publicado: (2009) -
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
por: Alazzoni, Ashraf, et al.
Publicado: (2012) -
Novel drug-eluting stents in the treatment of de novo coronary lesions
por: Capodanno, Davide, et al.
Publicado: (2011)